IBRX
Immunitybio Inc
NASDAQ · Biotechnology
$6.05
+0.41 (+7.27%)
Performance
1D
—
1W
-1.31%
1M
+133.59%
3M
+182.71%
6M
+114.54%
1Y
+78.47%
YTD
+199.50%
Open$5.70
Previous Close$5.64
Day High$6.08
Day Low$5.61
52W High$8.28
52W Low$1.83
Volume18.04M
Avg Volume27.02M
Market Cap5.96B
P/E Ratio—
EPS$-0.41
SectorBiotechnology
Volume Analysis
0.67x average volume
Technical Indicators
SMA 50
$3.46
Above
SMA 200
$2.77
Above
RSI (14)
54.9
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
11 analysts
Price Target
+1,698.2% upside
Current
$6.05
$6.05
Target
$108.79
$108.79
$71.54
$108.79 avg
$142.95
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 20.78M | 1.55B | 1.61B |
| Net Income | -584,182,873 | 174.18M | 206.87M |
| Profit Margin | -2,804.8% | 11.2% | 12.9% |
| EBITDA | -446,386,239 | 310.76M | 319.11M |
| Free Cash Flow | — | 125.72M | 219.44M |
| Rev Growth | +151.2% | +14.4% | +15.1% |
| Debt/Equity | 0.01 | 0.68 | 0.80 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |